Truveta Announces Strategic Collaboration with Pfizer to Accelerate Safety Insights in Real Time

Real World Data on a grand scale empowers Pfizer to identify, monitor, and evaluate potential signals immediately using complete Electronic Medical Record data, updated daily for more than 50 million people

BELLEVUE, Wash. – June 21, 2022 - Truveta today announced a strategic collaboration with Pfizer to deliver new safety insights on a continuous basis, using verifiable real-world data at scale. Truveta will provide Pfizer with an unprecedented data platform for research. The data collected by Truveta are always flowing, providing the most up-to-date picture of U.S. health. Pfizer will use de-identified data from Truveta to identify, monitor, and evaluate potential signals in near-real time, informing efforts to mitigate risks and enabling further research.

Truveta is the world’s first health system-led data platform with a vision of Saving Lives with Data. Truveta’s 20 innovative health system members provide more than 16 percent of U.S. patient care from tens of thousands of clinical care sites across 42 states and provide ongoing governance to Truveta.

“Truveta’s dataset is one of the most timely and complete datasets available in the United States, allowing Pfizer to learn directly from de-identified patient data at an unprecedented pace and scale,” said Dr. Aida Habtezion, Chief Medical Officer, and Head of Worldwide Medical and Safety, Pfizer. “This enhances our best-in-class monitoring systems, through near real-time monitoring of safety signals in an expansive patient population. We hope to continue to find additional benefit from this growing data such as identifying and addressing health disparities.”

“Truveta’s vision is Saving Lives with Data, and we are inspired to work with Pfizer to fight the devastating impacts of COVID-19 and other health conditions,” said Terry Myerson, CEO of Truveta. “We are excited to work closely with Pfizer as we build the largest and most complete data platform for U.S. health, readily accessible through a complete analytics solution. With Truveta, researchers can be empowered with real-time data to find cures, advance patient care, and transform healthcare in the U.S. The world needs answers to medical questions faster and together, we can help.”

Learning in Real Time with Real World Data

Truveta’s data platform empowers researchers to quickly monitor, query and evaluate health data from more than 50 million?de-identified patient journeys, covering a broad range of diversity of the U.S. Data are updated daily and includes the full Electronic Medical Record (EMR), not just the medical bill from claims data, all fully anonymized and aggregated. This clinical data is linked across providers and with medical claims when care is provided outside Truveta’s network. Every patient record is enhanced with comprehensive socio-economic data and daily mortality data for a complete picture of each patient’s health journey.

Putting the Researcher at the Center with Trusted Data

In close partnership with its health system members, Truveta puts the researcher front and center in their efforts - creating the opportunity to access data for real-time learning. Truveta’s learning community connects life science and health?systems to innovate collaboratively,? speed time to insights, and earn trust?through transparency and? reproducibility of research.

“As the first health system to deliver the first COVID-19 vaccine outside of a clinical trial from Pfizer-BioNTech in the U.S., we are thrilled to join together as we continue to fight this pandemic,” said Michael Dowling, President and CEO of Northwell Health.?“The collaboration between Pfizer and Truveta is an extraordinary partnership between life science and our nation’s health systems all working together to?ensure our communities are best protected from COVID and other health conditions.”??

About Truveta

Truveta is the world’s first health system-led data platform with a vision of Saving Lives with Data. Through partnerships with more than 20 innovative health system members, the Truveta platform represents the full diversity of our country across age, geography, race, ethnicity, and gender. Truveta aims to help researchers find cures faster, empower every clinician to be an expert, and help families make the most informed decision about their care. Truveta’s platform is licensed for ethical medical research, not for targeting advertising to patients or physicians. Truveta is a tax paying entity. To learn more, please follow us on?LinkedIn?and visit?truveta.com.

About Truveta’s Members

Truveta’s members provide more than 16 percent of U.S. patient care from tens of thousands of clinical care sites across 42 states and provide ongoing governance to Truveta. Truveta membership includes?Providence,?Advocate Aurora Health,?Trinity Health,?Tenet Healthcare,?Northwell Health,?AdventHealth,?Baptist Health of Northeast Florida,?Baylor Scott & White Health,?Bon Secours Mercy Health,?CommonSpirit Health,?Hawaii Pacific Health,?Henry Ford Health System,?MedStar Health,?Memorial Hermann Health System,?Novant Health,?Ochsner Health,?Saint Luke’s Health System,?Sentara Healthcare,?Texas Health Resources?and?UnityPoint Health.

Kenia Cortés

Bachelor's degree en Universidad Hispanoamericana (CR)

2 年

Congrats! Awesome job Terry Myerson!

回复
Alessandro Brozzi

Senior Data Scientist

2 年

Wow! “Today, the Truveta platform includes over 50 million unique, de-identified patient journeys (updated and growing daily). This is more than 5x the entire population of Israel and the data represents the full diversity of the U.S. across age, geography, race, ethnicity, and gender. Truveta’s membership represents over 700 hospitals and over 20,000 clinics, with clinical data from more than 20 leading health systems.” Kudos.

Laurie Kelley

Senior executive, board member, speaker, and community leader.

2 年

Congrats Terry Myerson and to the entire team Truveta! Really exciting and much needed collaboration to, as we say at Providence, "create health for a better world."

Congrats Terry! What a milestone.

Mitchell Gold M.D.

Former Executive Chairman and CEO Alpine Immune Sciences Founder and Managing Partner Alpine BioVentures

2 年

Congrats and way to change how we use data to improve health and safety for innovative new therapeutics.

要查看或添加评论,请登录

Terry Myerson的更多文章

社区洞察

其他会员也浏览了